Cost-Effectiveness Analysis In German Pharmaceutical Price Regulation
نویسندگان
چکیده
منابع مشابه
Comparative approaches to pharmaceutical price regulation in the European Union.
AIM To review pharmaceutical price regulation methods in countries of the European Union (EU), in terms of the anticipated impact of regulation on pharmaceutical expenditures and evidence of actual outcomes. METHOD An extensive search was performed of medical and economic studies on regulatory interventions specifically targeting pharmaceutical prices in EU countries, published between Januar...
متن کاملPrice regulation in the pharmaceutical industry: prescription or placebo?
President Clinton and several Legislators have proposed restrictions on price increases in the pharmaceutical industry similar to those on some public utilities. Studies, however, suggest that under conditions of rapidly changing demand (as found in pharmaceuticals), price-caps could be manipulated. Using simulations, we show that in reaction to regulation, pharmaceutical firms would optimally ...
متن کاملCost- Effectiveness Analysis of Infectious Waste Treatment Devices in Hospital
Introduction: Today, the infectious wastes of hospitals are considered as a public health problem. Considering the huge amounts of hazardous wastes and the disadvantages of incinerators, we need to investigate the non-combustible devices involved in biochemical treatment. This study was carried out with the aim of evaluating the cost-effectiveness of infectious wastes devices. Materials and Me...
متن کاملCost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia
Background There is limited evidence detailing the cost-effectiveness of psoriasis treatments in the Asian region. Therefore, this study is aimed to evaluate the cost-effectiveness of 3 psoriasis treatments tailored for moderate to severe psoriasis, namely topical and phototherapy (TP), topical and systemic (TS), and topical and biologic (TB) regimens, respectively. Me...
متن کاملPharmaceutical Regulation and Switching Cost: New Results in Old Skins
This paper analyzes the impact of a negotiated scheme and a generic reference price system in comparison to a simple copayment system in a vertical di¤erentiation model with switching costs. The duopolistic market structure with an o¤-patent brand-name drug competing in a Stackelberg-mode with a generic version is adopted from Merino-Castéllo 2003. Brand-name drug and generic version di¤er in p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2013
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.1339